Biologic Prior Authorization for Asthma: A Florida Patient Guide

What Is Prior Authorization for Biologics?

Prior authorization is a formal approval process that insurers require before they will cover a high-cost specialty medication. Asthma biologics typically cost $15,000–$40,000 per year without insurance, which is why virtually every commercial insurer, Medicare Advantage plan, and Florida Medicaid plan requires PA before the first dose.

The insurer reviews clinical evidence to confirm that:

• The patient has a qualifying diagnosis (severe persistent asthma)
• Standard controller therapy has been tried and failed
• The specific biologic requested is appropriate given the patient’s biomarker profile
• The prescription comes from a qualified specialist

PA is not a judgment on whether you deserve treatment. It is a documentation exercise. When the right clinical evidence is submitted, most first-time requests are approved.

Step Therapy Requirements in Florida

Step therapy means your insurer requires proof that you have tried and failed lower-cost treatments before they will cover a biologic. For asthma biologics, Florida commercial insurers typically require the following steps documented in your chart:

Step 1: High-Dose ICS-LABA Combination Therapy

You must have a documented trial of at least 12 weeks of a high-dose inhaled corticosteroid (ICS) plus long-acting beta-agonist (LABA) combination inhaler — such as fluticasone/salmeterol (Advair), budesonide/formoterol (Symbicort), or fluticasone furoate/vilanterol (Breo Ellipta). Most insurers also want documentation of adherence, not just a prescription fill.

Step 2: Documented Exacerbation History

Insurers require proof of ongoing uncontrolled asthma despite controller therapy, typically shown by:

• Two or more asthma exacerbations requiring systemic corticosteroids in the prior 12 months, or
• One severe exacerbation requiring emergency department visit or hospitalization

Exacerbation records — office visit notes, ED discharge summaries, pharmacy fill history for oral steroids — are critical supporting documents.

Step 3: Relevant Biomarker Testing

Each biologic requires specific biomarker evidence. The insurer will match your bloodwork to the requested agent:

• Nucala / Fasenra / Tezspire: Blood eosinophil count (CBC with differential)
• Xolair: Total IgE level + positive allergen-specific IgE or skin-prick test
• Dupixent: Blood eosinophil count and/or FeNO measurement

See our detailed guides on blood eosinophil testing and FeNO testing for how to prepare for these tests and interpret results.

Step 4: Specialist Prescribing Requirement

Most Florida insurers require that the biologic be prescribed by a board-certified allergist or pulmonologist, not a primary care physician. Dr. Frank Hull is board-certified in Pulmonary and Critical Care Medicine, satisfying this requirement for all five approved biologics.

Documentation Checklist for Biologic PA

Incomplete submissions are the primary cause of PA delays. Submit all of the following with the initial request to avoid back-and-forth:

Florida Insurer PA Requirements at a Glance

While all major Florida insurers follow the same general step therapy framework, there are meaningful differences in thresholds, turnaround times, and appeal processes. The table below reflects general requirements as of 2026 — always verify with the current formulary, as criteria update annually.

Criteria are general guidance based on publicly available formulary policies; verify with the patient’s current plan year documents. Thresholds change annually at formulary review.

Your Rights Under Florida Law

Florida enacted step therapy reform through Florida Statute § 627.42393, effective July 2019. This law applies to fully insured commercial health plans regulated by the Florida Office of Insurance Regulation. Key protections include:

Right to a Step Therapy Exception

Your insurer must grant a step therapy exception (bypassing the required step therapy) when any of the following are documented:

• The required step therapy drug is contraindicated for you
• You are likely to have an adverse reaction or drug interaction with the required drug
• The required step therapy drug is clinically ineffective based on your history
• You have already tried and failed the required drug (documented prior to enrollment)
• The required step therapy process would seriously jeopardize your health or life

Mandatory Timelines

Under Florida law and applicable federal rules (for plans subject to ACA), insurers must issue:

• Non-urgent PA decisions: within 14 calendar days
• Urgent/expedited decisions: within 72 hours
• Concurrent review decisions: within 24 hours if health is at risk

Important Limitation

Florida’s step therapy statute applies to fully insured commercial plans regulated by the state. Self-funded employer plans (ERISA plans) are governed by federal law and are not subject to Florida’s step therapy statute. If your insurance is through a large employer’s self-funded plan, appeal rights are governed by ERISA and the plan documents rather than Florida statute. Your HR benefits administrator can confirm whether your plan is fully insured or self-funded.

PA Timeline: What to Expect Step by Step

From the day your physician decides a biologic is appropriate to the day you receive your first injection, the typical timeline in Florida looks like this:

Total time from clinical decision to first injection: 2–4 weeks for straightforward approvals; 4–8 weeks if an appeal is required.

Bridging therapy: During the PA process, we continue optimizing your existing controller regimen and may prescribe a short oral corticosteroid burst if you experience a significant exacerbation while waiting.

When PA Is Denied: The Appeal Process

An initial PA denial is not the end of the road. Approximately 50-60% of biologic PA denials are overturned on physician peer-to-peer review. Here is the structured appeal pathway:

Step 1: Request the Denial Reason in Writing

Your insurer must provide a written explanation of the denial with the specific clinical criteria not met. This document drives the appeal strategy.

Step 2: Physician Peer-to-Peer Review

Your prescribing physician requests a live phone call with the insurer’s medical director. This must typically be requested within 24-72 hours of the denial. On the call, Dr. Hull presents your case directly, addressing the specific criteria cited in the denial. This is the most effective and fastest appeal pathway.

Step 3: Formal First-Level Appeal

If peer-to-peer fails, a formal written appeal is submitted. Supporting documentation should include:

• A detailed letter of medical necessity addressing the specific denial criteria
• Relevant peer-reviewed literature supporting biologic use in your clinical profile
• Published clinical guidelines (GINA, NAEPP) supporting the request
• Any new biomarker data or clinical information obtained since the initial submission

Step 4: Independent External Review

For fully insured Florida commercial plans, you can request an independent external review through the Florida Department of Financial Services if the internal appeal is denied. The external reviewer is not affiliated with your insurer. This process takes up to 45 days (7 days for urgent cases).

Step 5: Manufacturer Bridge Programs

While appeals are in progress, most biologic manufacturers offer free drug bridge programs that can provide 60-90 days of medication at no cost while the PA process resolves. Our clinic coordinates enrollment in these programs simultaneously with the appeal process so you are not forced to wait without treatment.

Manufacturer Patient Assistance Programs

Even with insurance coverage, biologics carry significant out-of-pocket costs for commercially insured patients. Every FDA-approved asthma biologic has manufacturer programs to reduce or eliminate patient cost-sharing:

Important: Manufacturer copay programs cannot be used with Medicare, Medicaid, or other government-funded insurance. Eligibility requirements vary by program and may include income criteria. Our clinic staff can help you determine which programs you qualify for and assist with enrollment.

How Advanced Asthma Clinic Manages Your Prior Authorization

At Advanced Asthma Clinic in Plantation, FL, biologic prior authorization is a core part of what we do — not an afterthought. Dr. Frank Hull has been prescribing asthma biologics for over 20 years and our team understands exactly what Florida insurers require.

What We Do for Every Biologic Patient

• Pre-authorization biomarker workup: We order and document every biomarker required before initiating the PA request, so there are no gaps in your file. See our guides on blood eosinophil testing, FeNO testing, and lung function testing.
• Complete documentation package: We compile spirometry, exacerbation history, controller therapy records, and a physician letter of medical necessity before submitting — reducing the chance of an information request that delays the decision.
• Specialist PA submission: Our clinical staff submits directly to the insurer’s specialty pharmacy partner, tracking status daily.
• Rapid peer-to-peer response: If a denial is issued, Dr. Hull is available for peer-to-peer within 24-48 hours.
• Manufacturer program enrollment: We enroll eligible patients in copay assistance programs before the first injection so that approval never waits on financial paperwork.
• Bridge program coordination: If your first injection needs to be delayed while PA resolves, we coordinate free medication through manufacturer bridge programs.

Choosing the Right Biologic Before Starting PA

The most common reason a biologic PA fails is that the requested agent does not match the patient’s biomarker profile in a way the insurer’s criteria recognize. Before initiating any PA, Dr. Hull reviews your complete biomarker panel and selects the agent most likely to be approved and most likely to work for your specific asthma phenotype. See our complete biologic comparison guide for a detailed look at how the five agents differ by mechanism, biomarker eligibility, and dosing.

Frequently Asked Questions